Efficacy and safety of onceweekly semaglutide versus oncedaily insulin glargine as addon to metformin (with or without sulfonylureas) in insulinnaive patients with type 2 diabetes (SUSTAIN 4): a randomised, openlabel, parallelgroup, multicentre, multinational, phase 3a trial
A licensed provider can help you compare both options
In addition, we discuss the increase in the endogenous secretion of this hormone through various stimuli (e.g., carbohydrates, proteins, gut microbiota, bacteria-derived molecules, bile acids, lipids, fatty acids, polyphenols, etc.) or by the increase of GLP-1-producing cells, i.e., L-cells, which can be an appropriate approach for the management of diabetes
Forty-one percent said they dont have enough visit time to support patients after prescribing GLP-1 medications, and nearly half reported uncertainty about when GLP-1s are clinically appropriate in the first place